Position in CELC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$692,689
New position
Shares Held
6,621
first reported quarter
Ownership
0.014%
of shares outstanding
% of Portfolio
0.44%
of 13F equity value
Holder Rank
#157
of 273 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026BRANDYWINE MANAGERS, LLC holds $6,467,823 across 11 Biotechnology names. CELC ranks #6 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BEAM |
Beam Therapeutics Inc.
|
25,455 | $873,615 | |
| 2 | KYMR |
Kymera Therapeutics, Inc.
|
7,570 | $868,051 | |
| 3 | RLAY |
Relay Therapeutics, Inc.
|
38,429 | $719,006 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
13,357 | $716,870 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,318 | $697,787 | |
| 6 | CELC |
Celcuity Inc.
This page
|
6,621 | $692,689 | |
| 7 | MRNA |
Moderna, Inc.
|
9,510 | $665,985 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
12,301 | $479,862 |
All Filings in CELC
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $692,689 | 6,621 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||